Viewing Study NCT04921527


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2025-12-26 @ 4:12 AM
Study NCT ID: NCT04921527
Status: RECRUITING
Last Update Posted: 2024-10-18
First Post: 2021-06-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer
Sponsor: Chipscreen Biosciences, Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Relapsed or Refractory View
None Chiauranib View
None Paclitaxel View
Keywords: